Showing results (51-60 of 261) with videos related to
Sort By:
Pageof 27
International Journal of Oncology|May 5, 2005
Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancyHiroko Takedatsu, Kohji Yoshimoto, Takashi Okamura, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the peripheryShoko Tanaka, Mamoru Harada, Takashi Mine, et al.Cancer Science|April 27, 2007
Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patientsYuji Sato, Toshiyoshi Fujiwara, Takashi Mine, et al.International Journal of Oncology|June 18, 2004
Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimenKazuo Mochizuki, Yuji Sato, Naotake Tsuda, et al.Journal of Immunological Methods|May 16, 2002
Measurement of interferon-gamma by high-throughput fluorometric microvolume assay technology systemNobukazu Komatsu, Shigeki Shichijo, Yoshiaki Maeda, et al.Current Medicinal Chemistry|February 15, 2014
Personalized peptide vaccine for treatment of advanced cancerTetsuro Sasada, Akira Yamada, Masanori Noguchi, et al.Human Vaccines & Immunotherapeutics|August 17, 2012
Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancerTetsuro Sasada, Masanori Noguchi, Akira Yamada, et al.Cancer Science|October 31, 2012
Next-generation peptide vaccines for advanced cancerAkira Yamada, Tetsuro Sasada, Masanori Noguchi, et al.Oncoimmunology|July 9, 2015
Personalized peptide vaccination for advanced colorectal cancerTetsuro Sasada, Shiro Kibe, Yoshito Akagi, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|June 22, 2017
Clinical development of immunotherapy for prostate cancerMasanori Noguchi, Noriko Koga, Tsukasa Igawa, et al.Pageof 27